Metabolic Activation of Tofacitinib Mediated by Myeloperoxidase in Vitro

Chem Res Toxicol. 2019 Dec 16;32(12):2459-2465. doi: 10.1021/acs.chemrestox.9b00280. Epub 2019 Nov 27.

Abstract

Tofacitinib (TFT) is used for the treatment of moderately and severely active rheumatoid arthritis. Unfortunately, TFT was reported to induce leukopenia, and the underlying mechanisms remain unclear. The present study demonstrated that TFT was oxidized to a chemically reactive nitrenium ion by myeloperoxidase (MPO) occurring in neutrophils. The electrophilic ion showed chemical reactivity toward N-acetyl-cysteine (NAC) to produce two TFT-NAC conjugates (M1 and M2) in incubation of TFT with leucocytes in the presence of NAC. The generation of the nitrenium ion was verified by HClO-mediated oxidation of TFT. In addition, the nitrenium ion was found to react with sulfhydryl groups of cysteine residues of cellular protein in leucocytes after exposure to TFT. The study facilitates the understanding of the mechanisms of TFT toxic action.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / chemistry
  • Activation, Metabolic / physiology
  • Animals
  • Antirheumatic Agents / chemistry
  • Antirheumatic Agents / metabolism
  • Antirheumatic Agents / toxicity*
  • Hypochlorous Acid / chemistry
  • Leukocytes / drug effects*
  • Leukocytes / metabolism
  • Leukopenia / etiology*
  • Peroxidase / metabolism*
  • Piperidines / chemistry
  • Piperidines / metabolism
  • Piperidines / toxicity*
  • Pyrimidines / chemistry
  • Pyrimidines / metabolism
  • Pyrimidines / toxicity*
  • Pyrroles / chemistry
  • Pyrroles / metabolism
  • Pyrroles / toxicity*
  • Rats, Sprague-Dawley

Substances

  • Antirheumatic Agents
  • Piperidines
  • Pyrimidines
  • Pyrroles
  • Hypochlorous Acid
  • tofacitinib
  • Peroxidase
  • Acetylcysteine